The start of AIDS Awareness Month puts a spotlight on how treatment for HIV and AIDS has progressed over the past 40 years. Treatment for HIV/AIDS has consistently seen progress each decade, since the ...

The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.

As the annual U.S. Conference on HIV/AIDS (USCHA) kicks off in Washington, D.C., this week with a focus on aging with HIV, Gilead Sciences is rolling out a corresponding awareness campaign ...

On the occasion of World AIDS Day on 1 December 2024, the International Antiviral (formerly AIDS) Society-USA (IAS-USA) has published new international guidelines for the treatment and prevention of ...

Last weekend, communities nationwide marked Black HIV/AIDS Awareness Day, or NBHAAD, during an urgent time for people living with the disease and those who support them. More than four decades after ...

FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced its program for the upcoming 25th International AIDS Conference (AIDS 2024), taking place in Munich, Germany ...

Recent statistics have unveiled troubling increases in HIV infection rates across the United States, particularly within diverse communities. This alarming trend highlights the importance of ...

Share on Pinterest The Trump administration’s plan to cut funding for HIV vaccine research comes at a time when the field is making progress. Victor Torres/Stocksy United The Trump administration ...

Dar es Salaam. Tanzania has officially registered Lenacapavir, a long-acting injectable drug for the prevention and control of HIV, marking what officials describe as a significant milestone in the ...

Fighting against an illness with no treatment and institutional racism, Black queer communities had to look inward for support.